The 23rd China International In Vitro Diagnostic Expo by CACLP and its concurrent activities will return from 21–23 March 2026, at the Xiamen International Expo Center in Fujian Province, China.

On June 4 2025, Elsevier officially released the 2024 CiteScore, a key metric used to assess the impact of academic journals. VIEW, jointly sponsored by China Professional Community of Experimental Medicine (CPCEM) and published by John Wiley & Sons, achieved a CiteScore of 14.5 for 2024.

The simple test that proves the theory of evolution.

CACLP Expo 2021 is going to be hosted from March 28th to 30th at Chongqing International Expo Center.

Studies have shown that COVID-19 correlates with lymphopenia and low T cell concentrations, and mild COVID-19 correlates with a strong T cell response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Identifying the genetic cause of epilepsy using whole genome sequencing could lead to better disease management.

Researchers from Duke-NUS Medical School, Erasmus University Medical Center, Yale-NUS College and Duke University have found a potential way to predict who will respond to cancer therapies that block Wnt production.

Recently, the centers for disease control and prevention in Africa and the African union commission jointly launched a Pathogen genome project (Pathogen Genomics Initiative, PGI).

A joint research team comprised of Professor Jeong Wook Lee and Ph.D. candidate Chang Ha Woo and Professor Gyoo Yeol Jung and Dr. Sungho Jang have together developed a SENSR (SENsitive Splint-based one-pot isothermal RNA detection) technolog

Using dried blood spot samples (DBS) is an accurate alternative to venous blood in detecting SARS-CoV-2 antibody tests, a new study by immunology experts at the University of Birmingham has found.

Caltech researchers have developed a new type of multiplexed test with a low-cost sensor that may enable the at-home diagnosis of a COVID infection through rapid analysis of small volumes of saliva or blood, without the involvement of a medi

An Imperial team has repurposed robotic technology normally used for synthetic biology research to help with testing for COVID-19.